1
|
MAEU254068350
|
45 PACKAGES 3139 CARTONS PHA RMACEUTICALS AS UNDER MUPIR OCIN OINT 2% 22GM NDC CODE:68 462018022 FDA PRODUCT CODE NO .: 61 G J J 81 H. T. S NO.: 3004.90.92.45 ANDA NO.: 90-4 80 THERAPEUTICE USE: - ANTI-, BACTERIAL OXCARBAZEPINE TAB 300MG 100 NDC CODE:684620138 01 FDA PRODUCT CODE NO.:-61 M C A 45 HTS NO.3004.90.9236 ANDA NO.:-77-802 THERAPEUTIC E USE:-ANTI CONVULSANT AGENT OMEPRAZOLE DR CAP 40MG 1000 NDC CODE:68462039710 FDA PRODUCT CODE NO.:62KCF10 HTS N O.3004.90.9255 ANDA NO.:91672 THERAPEUTICE USE: -TREATMEN T OF TREAT GASTROESOPHAGEAL R EFLUX DISEASE PRAMIPEXOLE TAB 0.125MG 90 NDC CODE:68462 033090 FDA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO.: 3004.90.92.40 ANDA NO.: 90-781 THERAPEUTICE USE: USED IN PA RKINSON#S DISEASE PRAMIPEXO LE TAB 1MG 90 NDC CODE:684620 33390 FDA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO.: 300 4.90.92.40 ANDA NO.: 90-781 THERAPEUTICE USE: USED IN PARKINSON#S DISEASE ROSUVASTAT IN TAB 10MG 1000 NDC CODE:684 62026210 61 J C A 16 3004.49 .00.10 79172 TO TREAT HIGH C HOLESTEROL AND RELATED CONDIT IONS, AND TO PREVENT CARDIOV ASCULAR DISEASE ROSUVASTATI N TAB 10MG 90 NDC CODE:68462026290 FDA PRODUCT CODE NO.:6 1 J C A 16 H. T. S NO.: 3004 .49.00.10 ANDA NO.: 079172 T HERAPEUTICE USE: - TO TREAT H IGH CHOLESTEROL AND RELATED C ONDITIONS, AND TO PREVENT CA RDIOVASCULAR DISEASE COMMER CIAL & CUSTOM INVOICE NO. F22652000978 DT. 27.05.2025 F226 52000983 DT. 27.05.2025 F2265 2001000 DT. 28.05.2025 F22652 001001 DT. 28.05.2025 S/BILL NO: 2238942 DT 28-MAY-2025 S/ BILL NO: 2238943 DT 28-MAY-202 5 S/BILL NO: 2238989 DT 28-MA Y-2025 S/BILL NO: 2238970 DT28-MAY-2025 GROSS WT. 10,796. 906 KGS NET WT.8827.441 KGS 14 DATA LOGGERS HUMIDITY:65 % SET TEMPERATURE : +18 DEGRE ES TEMPERATURE RANGE : +15 DE GREES TO +25 DEGREES NOTIFY P ARTY:2 GLENMARK PHARMACEUTICA LS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 U SA NOTIFY PARTY:3 GLENMARK S PECIALTY S.A. SWITZERLAND (GS SA) PLACE DU PORT 2 NEUCHATE L - 2000 SWITZERLAND
|
GLENMARK PHARMACEUTICALS INC., US
|
GLENMARK PHARMACEUTICALS LIMITED
|
2025-07-08
|
India
|
10820 Kgs
|
45 PKG
|
2
|
MAEU253901495
|
40 PACKAGES 1722 CARTONS PHA RMACEUTICALS AS UNDER ONDANSE TRON ODT 4MG 30UD NDC CODE:68 462015713 FDA PRODUCT CODE N O,:-61 T C A 26 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78-1 52 THERAPEUTICE USE:-ANTI -E, METIC MUPIROCIN OINT 2% 22GM NDC CODE:68462018022 FDA PRO DUCT CODE NO.: 61 G J J 81 H . T. S NO.: 3004.90.92.45 AN DA NO.: 90-480 THERAPEUTICE U SE: - ANTI-BACTERIAL DROSPIR ENONE/EE TAB 3/0.02MG 84 NDC CODE:68462072029 FDA PRODUCTCODE NO.: 65 J D A 39 H. T. S NO.: 3006.60.00.00 ANDA NO .: 204296 THERAPEUTICE USE: - ORAL CONTRACEPTIVE COMMERCI AL & CUSTOM INVOICE NO. F2265 2000967 DT. 26.05.2025 F22652 000974 DT. 27.05.2025 F226520 00975 DT. 27.05.2025 S/BILL NO: 2209931 DT 28-MAY-2025 S/B ILL NO: 2227488 DT 28-MAY-2025 S/BILL NO: 2213785 DT 28-MAY -2025 GROSS WT. 6,596.120 KGS NET WT.4806.416 KGS 03 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JE RSEY MAHWAH - 07430 USA
|
GLENMARK PHARMACEUTICALS INC., US
|
GLENMARK PHARMACEUTICALS LIMITED
|
2025-07-08
|
India
|
6610 Kgs
|
40 PKG
|
3
|
MAEU254423349
|
PART OF FCL 9 PACKAGES 391 CARTONS PHARMACEUTICALS AS U NDER VARENICLINE TABLETS 0. 5 MG & 1MG , (STARTING MONTH B OX) NDC NO. : 68462-895-04 F DA PRODUCT CODE : 65ZCA01 AND A NO. : 214255 H. T. S NO.:, 3004.90.99 THERAPEUTIC USE : USE AS AN AID TO SMOKING CES SATION TREATMENT COMMERCIAL & CUSTOM INVOICE NO. 8324364 43 DTD 21.05.2025 S/BILL NO:2 069414 DT 22-MAY-2025 GROSS W T. 1,028.500 KGS NET WT.90.32 0 KGS 02 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES
|
GLENMARK PHARMACEUTICALS INC., US
|
MANKIND PHARMA LTD
|
2025-07-01
|
India
|
1030 Kgs
|
9 PKG
|
4
|
MAEU254068352
|
PART OF FCL 30 PACKAGES 14 53 CARTONS PHARMACEUTICALS AS UNDER NORETH ACE/EE TAB 1/ 0.02MG 63 NDC CODE:6846201328 1 FDA PRODUCT CODE NO.:65 J C A 25 H. T. S NO.: 3006.60. 00.00 ANDA NO.:206969 THERAP, EUTICE USE: - SECONDARY AMEN ORRHEA,ENDOMETRIOS IS AND ABN ORMAL UTERINE BLEEDING DRO SPIRENONE/EE TAB 3/0.02MG 84 NDC CODE:68462072029 FDA PROD UCT CODE NO.: 65 J D A 39 H. T. S NO.: 3006.60.00.00 AND A NO.: 204296 THERAPEUTICE USE: - ORAL CONTRACEPTIVE CO MMERCIAL & CUSTOM INVOICE NO. F22652000937 DT. 25.05.2025 F22652000938 DT. 25.05.2025 G ROSS WT. 4,354.900 KGS NET WT .3001.390 KGS 02 DATA LOGGE RS HUMIDITY:65% SET TEMPERAT URE : +18 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DE GREES S/BILL NO: 2182894 DT :27-MAY-25 S/BILL NO: 2166195 DT:26-MAY-25 NOTIFY PART Y:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NE W JERSEY MAHWAH - 07430 USA
|
GLENMARK PHARMACEUTICALS INC., US
|
GLENMARK PHARMACEUTICALS LIMITED
|
2025-07-01
|
India
|
4364 Kgs
|
30 PKG
|
5
|
MAEU254068353
|
47 PACKAGES 2175 CARTONS PHA RMACEUTICALS AS UNDER OLMES ARTAN MEDOX TAB 40MG 30 NDC C ODE:68462043830 FDA PRODUCT C ODE NO.: 62CCA68 H. T. S NO. : 3004.90.9220 ANDA NO.: 203 281 THERAPEUTICE USE: - -TRE, ATMENT OF HYPERTENSION, ALONE OR WITH OTHER ANTIHYPERTENS IVE AGENTS, TO LOWER BLOOD PR ESSURE GABAPENTIN TAB 600MG 500 NDC CODE:68462012605 FD A PRODUCT CODE:NO : 61 N C A 69 HTS NO.3004.90.9236 ANDA NO.:-77-662 THERAPEUTICE USE:-ANTICONVULSANT OMEPRAZOLE DR CAP 40MG 1000 NDC CODE:68 462039710 FDA PRODUCT CODE N O.:62KCF10 HTS NO.3004.90.925 5 ANDA NO.:91672 THERAPEUTIC E USE: -TREATMENT OF TREAT G ASTROESOPHAGEAL REFLUX DISEAS E MUPIROCIN OINT 2% 22GM NDC CODE:68462018022 FDA PRODU CT CODE NO.: 61 G J J 81 H. T. S NO.: 3004.90.92.45 ANDA NO.: 90-480 THERAPEUTICE USE : - ANTI-BACTERIAL COMME RCIAL & CUSTOM INVOICE NO. F2 2652000912 DT. 24.05.2025 F22 652000913 DT. 24.05.2025 F22652000931 DT. 25.05.2025 F2265 2000940 DT. 25.05.2025 S/BILL NO:2159730 DT 26-MAY-2025 S/ BILL NO:2159731 DT 26-MAY-2025 S/BILL NO:2158337 DT 26-MAY- 2025 S/BILL NO:2158336 DT 26- MAY-2025 GROSS WT. 10,697.2 12 KGS NET WT.9049.366 KGS 02 DATA LOGGERS SET TEMPERAT URE : +18 DEGREES NOTIFY PA RTY:2 GLENMARK PHARMACEUTICAL S INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 US A
|
GLENMARK PHARMACEUTICALS INC., US
|
GLENMARK PHARMACEUTICALS LIMITED
|
2025-07-01
|
India
|
10720 Kgs
|
47 PKG
|
6
|
MAEU254068351
|
45 PACKAGES 1680CARTONS PHAR MACEUTICALS AS UNDER OMEPRA ZOLE DR CAP 40MG 1000 NDC COD E:68462039710 FDA PRODUCT COD E NO.:62KCF10 HTS NO.3004.90 .9255 ANDA NO.:91672 THERAPE UTICE USE: -TREATMENT OF TREA, T GASTROESOPHAGEAL REFLUX DI SEASE ZONISAMIDE CAP 25MG 1 00 NDC CODE:68462012801 FDA PRODUCT CODE NO.:-61 M C E 44 H. T. S NO.: 3004.49.00.20 ANDA NO.:-77-651 THERAPEUTIC E USE:-ANTISEIZURE DRUG ON DANSETRON ODT 4MG 30UD NDC CODE:68462015713 FDA PRODUCT CO DE NO,:-61 T C A 26 H. T. S NO.: 3004.90.92.40 ANDA NO.: -78-152 THERAPEUTICE USE:-ANT I -EMETIC MUPIROCIN OINT 2 % 22GM NDC CODE:68462018022 FDA PRODUCT CODE NO.: 61 G J J 81 H. T. S NO.: 3004.90.92.45 ANDA NO.: 90-480 THERAPE UTICE USE: - ANTI-BACTERIAL COMMERCIAL & CUSTOM INVOICE NO. F22652000966 DT. 26.05.20 25 F22652000965 DT. 26.05.202 5 S/BILL NO: 2199667 DT 27-MA Y-2025 S/BILL NO: 2199894 DT 27-MAY-2025 GROSS WT. 8,529.407 KGS NET WT.7018.957 KGS 02 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREE S TEMPERATURE RANGE : +15 DEG REES TO +25 DEGREES NOTIFY PA RTY:2 GLENMARK PHARMACEUTICAL S INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA
|
GLENMARK PHARMACEUTICALS INC., US
|
GLENMARK PHARMACEUTICALS LIMITED
|
2025-07-01
|
India
|
8547 Kgs
|
45 PKG
|
7
|
MAEU253901497
|
45 PACKAGES 2069 CARTONS PHA RMACEUTICALS AS UNDER LIDOC AINE OINT JAR 5% 50GM NDC COD E:68462041827 FDA PRODUCT COD E NO.:60 Q C J 07 H. T. S NO .: 3004.49.00.50 ANDA NO.:20 6498 THERAPEUTICE USE: -USED, TO TEMPORARILY RELIEVE PAIN AND ITCHING ASSOCIATED WITH S KIN MUPIROCIN OINT 2% 22GM NDC CODE:68462018022 FDA PRO DUCT CODE NO.: 61 G J J 81 H . T. S NO.: 3004.90.92.45 AN DA NO.: 90-480 THERAPEUTICE U SE: - ANTI-BACTERIAL OMEPRAZOLE DR CAP 40MG 90 NDC CODE :68462039790 FDA PRODUCT CODE NO.:62KCF10 HTS NO.3004.90. 9255 ANDA NO.:91672 THERAPEU TICE USE: -TREATMENT OF TREAT GASTROESOPHAGEAL REFLUX DIS EASE INDOMETHACIN CAP 25MG 100 NDC CODE:68462040601 FDA PRODUCT CODE NO.: 62 G C E 4 2 H. T. S NO.: 3004.90.92.40 ANDA NO.:91-276 THERAPEUTIC E USE: -ANTI-INFLAMATORY I NDOMETHACIN CAP 25MG 1000 NDC CODE:68462040610 FDA PRODUCT CODE NO.: 62 G C E 42 H. T. S NO.: 3004.90.92.40 ANDA NO.:91-276 THERAPEUTICE USE: -ANTI-INFLAMATORY ALYACEN 1 /35 TAB 1/0.035MG 84 NDC CODE :68462039429 FDA PRODUCT CODE NO.: 65 J D A 24 H. T. S NO .: 3006.60.00.00 ANDA NO.: 0 91634 THERAPEUTICE USE: ORAL CONTRACEPTIVE COMMERCIAL& CUSTOM INVOICE NO. F2265200 0832 DT. 19.05.2025 F22652000 837 DT. 19.05.2025 F226520008 38 DT. 19.05.2025 F2265200085 3 DT. 21.05.2025 S/BILL NO:20 45296 DT 22-MAY-2025 S/BILL N O:1993571 DT 20-MAY-2025 S/BI LL NO:1993822 DT 20-MAY-2025S/BILL NO:2042260 DT 22-MAY-20 25 GROSS WT. 11,140.261 KGS NET WT.8975.412 KGS 02 DATA LOGGERS HUMIDITY:65% SET TE MPERATURE : +18 DEGREES TEMPE RATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 G LENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERS EY MAHWAH - 07430 USA
|
GLENMARK PHARMACEUTICALS INC., US
|
GLENMARK PHARMACEUTICALS LIMITED
|
2025-07-01
|
India
|
11163 Kgs
|
45 PKG
|
8
|
MAEU253901508
|
49 PACKAGES 1875 CARTONS PHA RMACEUTICALS AS UNDER ZONIS AMIDE CAP 100MG 100 NDC CODE: 68462013001 FDA PRODUCT CODE NO.:-61 M C E 44 H. T. S NO. : 3004.49.00.20 ANDA NO.:-77 -651 THERAPEUTICE USE:-ANTIS, EIZURE DRUG ROPINIROLE TAB 1MG 100 NDC CODE:68462025501 FDA PRODUCT CODE NO.:-62 J C A 17 H. T. S NO.: 3004.90.9 2.40 ANDA NO.:- 90-135 THERA PEUTICE USE:-TREATMENT OF PA RKINSONISM OMEPRAZOLE DR CA P 20MG 1000 NDC CODE:68462039610 FDA PRODUCT CODE NO.:62K CF10 HTS NO.3004.90.9255 AND A NO.:91672 THERAPEUTICE USE: -TREATMENT OF TREAT GASTROE SOPHAGEAL REFLUX DISEASE F LUCONAZOLE TAB 150MG 12UD NDC CODE:68462011944 NDC CODE : 68462011944 HTS NO : 3004.90.92.45 FDA CODE : 61 W C A 45 ANDA NO. : 77 - 253 THERAPE UTICE USE : ANTIFUNGAL MUP IROCIN OINT 2% 22GM NDC CODE: 68462018022 FDA PRODUCT CODE NO.: 61 G J J 81 H. T. S NO. : 3004.90.92.45 ANDA NO.: 90 -480 THERAPEUTICE USE: - ANTI-BACTERIAL OMEPRAZOLE DR C AP 20MG 1000 NDC CODE:6846203 9610 FDA PRODUCT CODE NO.:62 KCF10 HTS NO.3004.90.9255 AN DA NO.:91672 THERAPEUTICE USE : -TREATMENT OF TREAT GASTRO ESOPHAGEAL REFLUX DISEASE LITHIUM CARB CAP 300MG 1000 NDC CODE:68462022110 FDA PRODU CT CODE NO.:-61 N C E 37 H. T. S NO.: 3004.49.00.20 ANDA NO.:- 79 -139 THERAPEUTICE USE:-ANTIMANIC AGENT COMMER CIAL & CUSTOM INVOICE NO. F22 652000861 DT. 21.05.2025 F226 52000860 DT. 21.05.2025 F22652000862 DT. 21.05.2025 F22652 000875 DT. 22.05.2025 F226520 00876 DT. 22.05.2025 S/BILL N O:2045305 DT 22-MAY-2025 S/BI LL NO: 2059427 DT 22-MAY-2025 S/BILL NO: 2059449 DT 22-MAY- 2025 S/BILL NO: 2069412 DT 22 -MAY-2025 S/BILL NO:2069416 DT 22-MAY-2025 GROSS WT. 10,11 5.950 KGS NET WT.8305.49 KGS 02 DATA LOGGERS HUMIDITY:6 5% SET TEMPERATURE : +18 DEGR EES TEMPERATURE RANGE : +15 D EGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTIC ALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA
|
GLENMARK PHARMACEUTICALS INC., US
|
GLENMARK PHARMACEUTICALS LIMITED
|
2025-07-01
|
India
|
10137 Kgs
|
49 PKG
|
9
|
MAEU254178145
|
PART OF FCL 16 PACKAGES 18 17 CARTONS PHARMACEUTICALS AS UNDER VARENICLINE TABLETS 1 MG, 56CT NDC NO. : 68462-89 4-56 FDA PRODUCT CODE : 65ZCA 01 ANDA NO. : 214255 H. T. S NO.: 3004.90.99 THERAPEUTIC, USE : USE AS AN AID TO SMOK ING CESSATION TREATMENT VAR ENICLINE TABLETS 1 MG, 56CT N DC NO. : 68462-894-56 FDA PRO DUCT CODE : 65ZCA01 ANDA NO. : 214255 H. T. S NO.: 3004.9 0.99 THERAPEUTIC USE : USE AS AN AID TO SMOKING CESSATION TREATMENT VARENICLINE TABL ETS 1 MG, 56CT NDC NO. : 6846 2-894-56 FDA PRODUCT CODE : 6 5ZCA01 ANDA NO. : 214255 H. T. S NO.: 3004.90.99 THERAPE UTIC USE : USE AS AN AID TO SMOKING CESSATION TREATMENT VARENICLINE TABLETS 1 MG, 56CT NDC NO. : 68462-894-56 FDA PRODUCT CODE : 65ZCA01 ANDA NO. : 214255 H. T. S NO.: 30 04.90.99 THERAPEUTIC USE : USE AS AN AID TO SMOKING CESSA TION TREATMENT COMMERCIAL & CUSTOM INVOICE NO. 832436426 DTD 15.05.2025 S/BILL NO: 1952773 DT: 19/05/2025 02 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JE RSEY MAHWAH - 07430 USA
|
GLENMARK PHARMACEUTICALS INC., US
|
MANKIND PHARMA LTD
|
2025-06-23
|
Oman
|
2667 Kgs
|
16 PKG
|
10
|
MAEU254244878
|
PART OF FCL 5 PACKAGES 457 C ARTONS PHARMACEUTICALS AS UND ER BUMETANIDE INJECTION USP 2.5MG/10ML (0.25MG/ML) NDC N O. : 68462-470-54 FDA PRODUCT CODE : 64BCK09 ANDA NO. : 21 6434 H. T. S NO.: 3004.90.92, 59 COMMERCIAL & CUSTOM INVO ICE NO. M72617000050 DT 06.05 .2025 S/BILL NO: 1741967 DT: 13/05/2025 GROSS WT. 2,461.83 0 KGS NET WT.2118.652 KGS 02 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC., USA 301, ISLAND RD NEW JE RSEY MAHWAH USA- 07430 LABE LER CODE : 68462:
|
GLENMARK PHARMACEUTICALS INC., US
|
GLAND PHARMA LIMITED
|
2025-06-23
|
Oman
|
2467 Kgs
|
5 PKG
|